EUVIMEDEUVIMED entdecken
Beobachtungsstudie

“Per ELISA”: Time to adopt anti-transglutaminase/deamidated gliadin peptide diagnostic combination in coeliac disease of adults?

Antonio Rispo, Giulio Calabrese, Benedetta Toro, Oriana Olmo, Simona Ricciolino, Nicola Mattia Cantisani, Lara Limansky, Miriam Giaquinto, Rossella Caso, Nicola Imperatore

Digestive and Liver Disease · 2024

DOI: 10.1016/j.dld.2024.03.002 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Antonio Rispo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy. Hauptthemen laut MEDLINE: Celiac Disease, Gliadin, Enzyme-Linked Immunosorbent Assay, Transglutaminases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Anti-endomysial antibodies (EMA) and anti-tissue transglutaminases (a-tTg) play a pivotal role in coeliac disease (CD) diagnosis. Deamidated anti-gliadin peptides (DGP) were added to the CD diagnostic workup. AIMS: We aimed to compare the diagnostic accuracies of ELISA-based (a-tTg/DGP) and immunofluorescence-ELISA-based strategies (EMA/a-tTg) for CD diagnosis. METHODS: From November 2020 to November 2022, we undertook an observational prospective study including consecutive adult patients with suspected CD. All subjects were tested for EMA, a-tTg and DGP IgA. An ROC curve was plotted to establish the best specificity cut-off of a-tTg and DGP levels, which would predict the presence of Marsh≥2 and Marsh=3. The diagnostic accuracies of a-tTg/DG and EMA/a-tTg were compared. RESULTS: The study included 275 CD patients. Histology showed Marsh=1 in 9.9%, Marsh=2 in 4.5%, and Marsh=3 in 85.6.%. The best cut-off value of a-tTg for predicting Marsh≥2 was 42 U/mL, while the best cut-off for predicting atrophy was 68.4 U/mL. The best cut-off value of DGP for predicting Marsh≥2 was 56 U/mL, while the best cut-off for predicting atrophy was 78 U/mL. A-tTg/EMA showed 97% sensitivity and 100% specificity, whereas a-tTg/DGP showed 94% sensitivity and 100% specificity. CONCLUSION: A-tTg/DGP is accurate for CD diagnosis and could reduce costs and operator-dependency of EMA. DGP, together with a-tTg, could replace EMA in CD diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseGliadinEnzyme-Linked Immunosorbent AssayTransglutaminasesHumansMaleFemaleAdultProspective StudiesMiddle AgedSensitivity and SpecificityAutoantibodiesROC CurveImmunoglobulin AAgedYoung Adult

Stichwörter der Autor:innen

Coeliac diseaseELISAGliadinGluten

Substanzen

GliadinTransglutaminasesAutoantibodiesImmunoglobulin A

Autor:innen und Institutionen

  • Gastroenterology, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy.
  • Gastroenterology, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy. Electronic address: giuliocalabrese94@gmail.com.
  • Gastroenterology, "Santa Maria Delle Grazie" Hospital, Pozzuoli, Naples, Italy.

Zitieren

APA

Rispo, A., Calabrese, G., Toro, B., Olmo, O., Ricciolino, S., Cantisani, N. M., Limansky, L., Giaquinto, M., Caso, R., & Imperatore, N. (2024). “Per ELISA”: Time to adopt anti-transglutaminase/deamidated gliadin peptide diagnostic combination in coeliac disease of adults?. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.03.002

Vancouver

Rispo A, Calabrese G, Toro B, Olmo O, Ricciolino S, Cantisani NM, et al. “Per ELISA”: Time to adopt anti-transglutaminase/deamidated gliadin peptide diagnostic combination in coeliac disease of adults?. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.03.002

BibTeX
@article{Rispo2024,
  author = {Rispo, Antonio and Calabrese, Giulio and Toro, Benedetta and Olmo, Oriana and Ricciolino, Simona and Cantisani, Nicola Mattia and Limansky, Lara and Giaquinto, Miriam and Caso, Rossella and Imperatore, Nicola},
  title = {“Per ELISA”: Time to adopt anti-transglutaminase/deamidated gliadin peptide diagnostic combination in coeliac disease of adults?},
  journal = {Digestive and Liver Disease},
  year = {2024},
  doi = {10.1016/j.dld.2024.03.002}
}
Kostenlos starten →